Cefdinir and Lantus solostar drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cefdinir (cefdinir) and Lantus solostar (insulin glargine recombinant). Common drug interactions include renal failure among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Cefdinir and Lantus solostar. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.
What is Cefdinir?
Cefdinir has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 9,210 Cefdinir users. Check the latest studies of Cefdinir.
What is Lantus solostar?
Lantus solostar has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 41,639 Lantus solostar users. Check the latest studies of Lantus solostar.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
27 people who take Cefdinir and Lantus solostar together, and have interactions are studied.

What are the common drug interactions of Cefdinir and Lantus Solostar, by gender? *:
female:
- Renal failure (kidney dysfunction)
- Chronic kidney disease
- Death
- Abdominal abscess (collection of pus in abdomen)
- Abscess (pus)
- Abscess limb (limb infection)
- Cellulitis (infection under the skin)
- Cellulitis gangrenous (localized inflammation of the soft or connective tissue with considerable mass of body tissue dies (necrosis))
- Nerve injury
- Pain
male:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Constipation
- Kidney infection
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Neoplasm malignant (cancer tumour)
- Obesity (having too much body fat)
- Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Blood creatinine increased
What are the common drug interactions of Cefdinir and Lantus Solostar, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Death
- Renal failure (kidney dysfunction)
- Chronic kidney disease
- Hypoaesthesia (reduced sense of touch or sensation)
50-59:
- Abdominal abscess (collection of pus in abdomen)
- Abscess (pus)
- Abscess limb (limb infection)
- Cellulitis (infection under the skin)
- Cellulitis gangrenous (localized inflammation of the soft or connective tissue with considerable mass of body tissue dies (necrosis))
- Nerve injury
- Pain
- Scar
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Skin necrosis (skin damage)
60+:
- Renal failure (kidney dysfunction)
- Chronic kidney disease
- Hyperhidrosis (abnormally increased sweating)
- Kidney infection
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Neoplasm malignant (cancer tumour)
- Obesity (having too much body fat)
- Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
- Visual impairment
- Blood creatinine increased
What are the existing conditions these people have? *
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 13 people, 48.15%
- High Blood Cholesterol: 9 people, 33.33%
- High Blood Pressure: 8 people, 29.63%
- Pain: 7 people, 25.93%
- Stress And Anxiety: 6 people, 22.22%
- Depression: 6 people, 22.22%
- Asthma: 5 people, 18.52%
- Infection: 4 people, 14.81%
- Bone Disorder: 4 people, 14.81%
- Cardiac Failure: 4 people, 14.81%
* Approximation only. Some reports may have incomplete information.
Do you take Cefdinir and Lantus solostar?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Cefdinir (9,210 reports)
- Lantus solostar (41,639 reports)
Browse all drug interactions of Cefdinir and Lantus solostar:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cefdinir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lantus solostar:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cefdinir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lantus solostar and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cefdinir and insulin glargine recombinant (the active ingredients of Cefdinir and Lantus solostar, respectively), and Cefdinir and Lantus solostar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Flonase Allergy Relief cause Infusion Site Warmth? - 2 seconds ago
- Could Skyrizi cause Heart Rate Increased? - 2 seconds ago
- Vasculitis and Gastric Ulcer - 9 seconds ago
- Could Lyrica cause Lip Dry? - 10 seconds ago
- Could Cipro cause Arterial Occlusive Disease? - 10 seconds ago
- Could Ezetimibe cause Sneezing? - 16 seconds ago
- Could Jakafi cause Abdominal Rigidity? - 24 seconds ago
- Could Calcium Carbonate cause Fungal Infection? - 30 seconds ago
- Could Dacarbazine cause Muscle Spasms? - 36 seconds ago
- Could Cogentin cause Neoplasm Malignant? - 38 seconds ago